PAPER Choi H, Park HH, Lee KY, Choi NY, Yu HJ, Lee YJ, Park J, Huh YM, Lee SH, Koh SH
SEARCH RESULTS
330026 RESULTS
PAPER Yuan J, Venkatraman S, Zheng Y, McKeever BM, Dillard LW, Singh SB
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease.
J Med Chem. 2013 Jun 13;56(11):4156-80. PubMed: 23509904PAPER McLean D, Cooke MJ, Albay R, Glabe C, Shoichet MS
Positron emission tomography imaging of fibrillar parenchymal and vascular amyloid-β in TgCRND8 mice.
ACS Chem Neurosci. 2013 Apr 17;4(4):613-23. PubMed: 23509918PAPER Ghavami M, Rezaei M, Ejtehadi R, Lotfi M, Shokrgozar MA, Abd Emamy B, Raush J, Mahmoudi M
Physiological temperature has a crucial role in amyloid beta in the absence and presence of hydrophobic and hydrophilic nanoparticles.
ACS Chem Neurosci. 2013 Mar 20;4(3):375-8. PubMed: 23509973PAPER Cook NP, Archer CM, Fawver JN, Schall HE, Rodriguez-Rivera J, Dineley KT, Martí AA, Murray IV
Ruthenium red colorimetric and birefringent staining of amyloid-β aggregates in vitro and in Tg2576 mice.
ACS Chem Neurosci. 2013 Mar 20;4(3):379-84. PubMed: 23509974PAPER Luo J, Yu CH, Yu H, Borstnar R, Kamerlin SC, Gräslund A, Abrahams JP, Wärmländer SK
Cellular polyamines promote amyloid-beta (aβ) peptide fibrillation and modulate the aggregation pathways.
ACS Chem Neurosci. 2013 Mar 20;4(3):454-62. PubMed: 23509981PAPER Di Scala C, Yahi N, Lelièvre C, Garmy N, Chahinian H, Fantini J
Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide.
ACS Chem Neurosci. 2013 Mar 20;4(3):509-17. PubMed: 23509984PAPER Hua Y, Guo X, Huang Q, Kong Y, Lu X
Association between interleukin-6-174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis.
Int J Neurosci. 2013 Apr 23; PubMed: 23510010PAPER Hampel H, Lista S
Have we learnt all we need to know from genetic studies- is genetics over in Alzheimer's disease?
Alzheimers Res Ther. 2013 Mar 18;5(2):11. PubMed: 23510020PAPER Kotarba AE, Aucoin D, Hoos MD, Smith SO, Van Nostrand WE
Fine mapping of the amyloid β-protein binding site on myelin basic protein.
Biochemistry. 2013 Apr 16;52(15):2565-73. PubMed: 23510371PAPER Chong ZZ, Shang YC, Mu Y, Cui S, Yao Q, Maiese K
Targeting erythropoietin for chronic neurodegenerative diseases.
Expert Opin Ther Targets. 2013 Jun;17(6):707-20. PubMed: 23510463PAPER Li RS, Wang XB, Hu XJ, Kong LY
Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Bioorg Med Chem Lett. 2013 May 1;23(9):2636-41. PubMed: 23511019PAPER Ogishima S, Mizuno S, Kikuchi M, Miyashita A, Kuwano R, Tanaka H, Nakaya J
A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
Clin Pharmacol Ther. 2013 May;93(5):399-401. PubMed: 23511713PAPER Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C,
Persistent use of Analgesic Medications in Mild-to-Moderate Alzheimer's Disease.
Drugs Aging. 2013 Jun;30(6):439-45. PubMed: 23512718PAPER Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD
The validity of dependence as a health outcome measure in Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2013 May;28(3):245-52. PubMed: 23512996Current Filters
No filters selected